Microbix Biosystems Inc. (MBXBF)
| Market Cap | 36.29M |
| Revenue (ttm) | 16.01M |
| Net Income (ttm) | 1.34M |
| Shares Out | n/a |
| EPS (ttm) | 0.01 |
| PE Ratio | 27.17 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,000 |
| Average Volume | 47,495 |
| Open | 0.2601 |
| Previous Close | 0.2600 |
| Day's Range | 0.2592 - 0.2631 |
| 52-Week Range | 0.2000 - 0.3870 |
| Beta | 0.29 |
| RSI | 46.16 |
| Earnings Date | May 9, 2025 |
About Microbix Biosystems
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for enabling the collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. I... [Read more]
News
Microbix & Aurevia Introduce Novel EQA Scheme
Pilot Program for Qualifying Clinical Labs to Diagnose Bacterial Vaginosis Pilot Program for Qualifying Clinical Labs to Diagnose Bacterial Vaginosis
Microbix Schedules Release of Results for Q2 Fiscal 2025
MISSISSAUGA, Ontario, May 08, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to...
Microbix Presenting at the 2025 Bloom Burton Conference
MISSISSAUGA, Ontario, May 01, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will be attend...
Microbix Provides Business Updates
MISSISSAUGA, Ontario, April 08, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF) (“Microbix®” or the Company”), a life sciences innovator, manufacturer, and exporter, provide...
Microbix Announces Annual and Special Meeting Voting Results
MISSISSAUGA, Ontario, March 27, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF) (“Microbix®” or the “Company”), a life sciences innovator and exporter, announces the voting ...
Microbix Further Optimizes Capital Usage and Availability
Debt Repayment & Credit Expansion Provides Savings & Maintains Resilience Debt Repayment & Credit Expansion Provides Savings & Maintains Resilience
Microbix & ACPCC support efforts to eliminate cervical cancer in the Indo-Pacific
EPICC HPV Elimination Partnership being supplied PROCEEDxFLOQ QAPs to Support Test Accuracy EPICC HPV Elimination Partnership being supplied PROCEEDxFLOQ QAPs to Support Test Accuracy
Microbix Presenting at Investor Conference in B.C.
MISSISSAUGA, Ontario, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be p...
Q1 2025 Microbix Biosystems Inc Earnings Call Transcript
Q1 2025 Microbix Biosystems Inc Earnings Call Transcript
Microbix Biosystems Inc. (MBXBF) Q1 2025 Earnings Call Transcript
Microbix Biosystems Inc. 2024 Q4 - Results - Earnings Call Presentation
Microbix Biosystems GAAP EPS of C$0.01, revenue of C$6.04B; initiates FY25 outlook
Microbix Reports Strong Revenues & Earnings for Q1 Fiscal 2025
MISSISSAUGA, Ontario, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its fi...
Microbix Biosystems raises C$2.4M from the partial exercise of expiring share purchase warrants
Microbix Receives $2.4 Million from Exercise of Warrants
Further Capital to Assist with Increasing Capabilities, Capacity, and Efficiency Further Capital to Assist with Increasing Capabilities, Capacity, and Efficiency
Microbix Biosystems Inc. (MBXBF) Q4 2024 Earnings Call Transcript
Microbix Biosystems GAAP EPS of $0.003, revenue of $6.29M
Microbix Reports Record Product Sales for Q4 and Fiscal 2024
MISSISSAUGA, Canada, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its fis...
Microbix Schedules Release of Results for Q4 Fiscal 2024
Results Release and Webinar Discussion on Morning of December 19, 2024 Results Release and Webinar Discussion on Morning of December 19, 2024
Microbix Assisting EMQN with Novel Genetic-Test EQA Program
For Rapid Identification of Patients Susceptible to Antibiotic-Induced Hearing Loss For Rapid Identification of Patients Susceptible to Antibiotic-Induced Hearing Loss
Microbix Biosystems initiates normal course issuer bid
Microbix Biosystems begins share repurchase program, plans to buy back up to 6.73 million shares through normal course issuer bid.
Microbix Announces Initiation of Normal Course Issuer Bid
MISSISSAUGA, Ontario, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®) (“Microbix” or the “Company”), a life sciences innovator, manufacturer, and exporte...
Microbix Presents Novel HSV Test Control at EMMD
MISSISSAUGA, Ontario, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is prese...
Microbix Achieves Essential EU Regulatory Accreditations
MISSISSAUGA, Ontario, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it has upgra...
Microbix Presenting at Muskoka Capital Conference
MISSISSAUGA, Ontario, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be...